Company profile
Tarsus Pharmaceuticals, Inc. Insider Trading
TARSEvery SEC Form 4 insider trading filing for Tarsus Pharmaceuticals, Inc. (TARS) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001819790
- Filings
- 169
- Insiders
- 17
- Last filing
- 2026-09-15
Activity summary
Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Wendy L Yarno.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Tarsus Pharmaceuticals, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $9.2M.
90 day insight
Over the last 90 days, Tarsus Pharmaceuticals, Inc. insiders bought $0 across 6 transactions with no open-market sales.
- Most active insider: Elizabeth Yeu Lin with 7 transactions totaling $2.1M.
- Largest single sale: $915K by William J Link PHD on Sep 15, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Wendy L Yarno | TARS | Option Exercise | 302 | — | — |
| Sep 15, 2026 | Wendy L Yarno | TARS | Option Exercise | 302 | — | — |
| Sep 15, 2026 | William J Link PHD | TARS | Option Exercise | 201 | — | — |
| Sep 15, 2026 | William J Link PHD | TARS | Sale10b5 | 11,675 | $78.33 | $915K |
| Sep 15, 2026 | William J Link PHD | TARS | Sale10b5 | 759 | $79.00 | $60K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TARS" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Tarsus Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →